GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $122,100,000 | +2.3% | 2,803,032 | +3.5% | 0.06% | +4.9% |
| Q4 2021 | $119,402,000 | +30.5% | 2,707,529 | +13.0% | 0.06% | +17.3% |
| Q3 2021 | $91,523,000 | +3.4% | 2,395,262 | +7.8% | 0.05% | +4.0% |
| Q2 2021 | $88,486,000 | +33.8% | 2,222,148 | +19.9% | 0.05% | +31.6% |
| Q1 2021 | $66,144,000 | -2.0% | 1,853,290 | +1.0% | 0.04% | -9.5% |
| Q4 2020 | $67,504,000 | -25.1% | 1,834,348 | -23.4% | 0.04% | -35.4% |
| Q3 2020 | $90,182,000 | -11.8% | 2,395,906 | -4.4% | 0.06% | -16.7% |
| Q2 2020 | $102,257,000 | -1.2% | 2,506,911 | -8.2% | 0.08% | -17.9% |
| Q1 2020 | $103,516,000 | -23.4% | 2,732,020 | -5.0% | 0.10% | -4.0% |
| Q4 2019 | $135,179,000 | +15.7% | 2,876,769 | +5.1% | 0.10% | +5.3% |
| Q3 2019 | $116,805,000 | +9.7% | 2,736,756 | +2.9% | 0.09% | +6.8% |
| Q2 2019 | $106,476,000 | -7.9% | 2,660,559 | -3.8% | 0.09% | -12.0% |
| Q1 2019 | $115,560,000 | +13.8% | 2,765,250 | +4.1% | 0.10% | -1.0% |
| Q4 2018 | $101,544,000 | -4.6% | 2,657,537 | +0.3% | 0.10% | +8.6% |
| Q3 2018 | $106,416,000 | +8.1% | 2,649,141 | +8.5% | 0.09% | 0.0% |
| Q2 2018 | $98,451,000 | +12.4% | 2,442,358 | +9.0% | 0.09% | +8.1% |
| Q1 2018 | $87,564,000 | +114.4% | 2,241,217 | +94.7% | 0.09% | +109.8% |
| Q4 2017 | $40,839,000 | -30.7% | 1,151,374 | -20.7% | 0.04% | -35.9% |
| Q3 2017 | $58,970,000 | +0.5% | 1,452,468 | +6.8% | 0.06% | -8.6% |
| Q2 2017 | $58,658,000 | +18.5% | 1,360,343 | +15.9% | 0.07% | -7.9% |
| Q1 2017 | $49,503,000 | +27.5% | 1,174,176 | +16.5% | 0.08% | +40.7% |
| Q4 2016 | $38,827,000 | -20.2% | 1,008,237 | -10.6% | 0.05% | -26.0% |
| Q3 2016 | $48,648,000 | +2.1% | 1,127,944 | +2.6% | 0.07% | -2.7% |
| Q2 2016 | $47,639,000 | +4.3% | 1,099,187 | -2.4% | 0.08% | +1.4% |
| Q1 2016 | $45,659,000 | +18.7% | 1,125,982 | +18.1% | 0.07% | +12.1% |
| Q4 2015 | $38,476,000 | +9.1% | 953,556 | +4.0% | 0.07% | -4.3% |
| Q3 2015 | $35,256,000 | -2.6% | 916,940 | +5.5% | 0.07% | -2.8% |
| Q2 2015 | $36,193,000 | -6.7% | 868,990 | +3.3% | 0.07% | -9.0% |
| Q1 2015 | $38,812,000 | +26.2% | 840,998 | +16.8% | 0.08% | +20.0% |
| Q4 2014 | $30,765,000 | +21.7% | 719,818 | +30.9% | 0.06% | +16.1% |
| Q3 2014 | $25,275,000 | -17.5% | 549,817 | -4.0% | 0.06% | -18.8% |
| Q2 2014 | $30,641,000 | +6.3% | 572,939 | +6.2% | 0.07% | +1.5% |
| Q1 2014 | $28,832,000 | +1.4% | 539,619 | +1.4% | 0.07% | -1.4% |
| Q4 2013 | $28,426,000 | +18.9% | 532,418 | +11.7% | 0.07% | +6.2% |
| Q3 2013 | $23,908,000 | +5.6% | 476,544 | +5.2% | 0.06% | -1.5% |
| Q2 2013 | $22,640,000 | – | 453,080 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |